Compare KTTA & KSCP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KTTA | KSCP |
|---|---|---|
| Founded | 2020 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Telecommunications Equipment |
| Sector | Health Care | Telecommunications |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.6M | 14.3M |
| IPO Year | 2021 | 2022 |
| Metric | KTTA | KSCP |
|---|---|---|
| Price | $0.48 | $0.34 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $12.00 |
| AVG Volume (30 Days) | ★ 1.4M | 903.4K |
| Earning Date | 11-13-2026 | 11-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 77.07 | 63.54 |
| EPS | ★ N/A | N/A |
| Revenue | $486,559.00 | ★ $11,335,000.00 |
| Revenue This Year | N/A | $186.44 |
| Revenue Next Year | N/A | $18.25 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 3130.37 | 4.91 |
| 52 Week Low | $0.32 | $0.35 |
| 52 Week High | $2.06 | $5.96 |
| Indicator | KTTA | KSCP |
|---|---|---|
| Relative Strength Index (RSI) | 49.53 | 29.15 |
| Support Level | $0.42 | N/A |
| Resistance Level | $0.57 | $0.55 |
| Average True Range (ATR) | 0.08 | 0.06 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 48.59 | 5.35 |
Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. The disorders covered includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module). The Company has reportable segment, which is the business of research and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers.
Knightscope Inc is a security technology and managed services company building the nation's first Autonomous Security Force (ASF), a unified force that integrates autonomous machines, software, real-time monitoring, and licensed security agents under a single managed service accountable for the security of the people, property, and places it protects. The company delivers the ASF as one integrated managed services offering that combines Autonomous Security Robots (ASRs), including the stationary K1 Hemisphere and the mobile K5; Emergency Communication Devices (ECDs); and Others. It generates revenue from subscription-based Machine-as-a-Service offerings, ECD product sales and related recurring service contracts, and Security Force agent and executive protection services.